SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the U.S. FDA approved its oral semaglutide for weight loss, a development enthusiastically celebrated by investors as a potential game-changer. The community views this as a critical catalyst for a strong stock reversal, expecting expanded market reach beyond injectables and a significant competitive edge in the burgeoning obesity treatment sector.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is experiencing extreme volatility following its recent IPO, driven by a low float and broad investor enthusiasm for the space sector. The community is highly polarized, with many celebrating significant gains and anticipating a continued short squeeze, while others voice concerns about the company's early stage of development, limited operations, and previously highlighted going concern risks.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following news of a significant $32.6 million U.S. Department of Defense contract aimed at resolving critical manufacturing bottlenecks in defense, alongside a $30 million private investment. The community is actively discussing expectations for further major aerospace and defense contract announcements, fueling bullish sentiment and talk of a potential short squeeze due to the stock's low float, despite some recent concerns regarding dilution.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following its largest-ever defense contract win and a flawless record of Electron launches, fueling broader excitement for the space sector and its role in national security. The community is actively debating whether recent gains reflect sustainable growth driven by its expanding prime contractor status and the anticipated re-rating of the space economy, or if profit-taking is imminent after its substantial run.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending amid high anticipation for its merger with Infleqtion, a quantum technology leader. Community discussion highlights Infleqtion's pivotal role in national security through advanced quantum sensing for GPS-independent navigation, bolstered by strategic partnerships with entities like NVIDIA and validation from Citron Research touting its superior technology over peers.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is attracting strong investor interest, fueled by recent bullish analyst coverage from Wedbush and Jefferies initiating Outperform ratings and highlighting the company's potential. The community is sharply divided, with proponents touting D-Wave's leadership in quantum annealing for optimization and its long-term market opportunity, while skeptics warn of speculative hype and significant cash burn in the nascent quantum computing sector. This intense debate highlights the ongoing divergence between fundamental valuation and market sentiment in emerging technologies.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending following new analyst coverage from Cantor Fitzgerald with a strong buy rating, yet investor discussions are dominated by frustration over the stock's significant decline. The community widely points to perceived market manipulation and recent brokerage restrictions on buying as primary drivers, questioning why the stock is under pressure despite its fundamental contracts and solid financial position.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending as recent exploration findings point to high-grade silver deposits, sparking optimism about its long-term potential amid a surging precious metals market. The community is actively discussing its status as a debt-free entity and significant insider investments, while some speculate on its valuation following a major prior investment exit. This has led to widespread debate on its rapid appreciation and future prospects.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing a historic surge, propelled by strong industrial demand for critical technologies like EV batteries and the impending Chinese silver export restrictions. The community is widely celebrating silver's breakout to new all-time highs, with many anticipating continued parabolic moves due to supply deficits and its role as a key inflation hedge. While some traders express caution about an extended rally, the prevailing sentiment points to a significant, long-awaited price discovery in the silver market.

WISeKey International Holding Ltd. is a cybersecurity company, which engages in offering digital security technology solutions. The firm operates through the Internet of Things (IoT), and Managed Public Key Infrastructure (mPKI) segments. The IoT segment refers to the design, manufacturing, sales and distribution of microprocessors operations. The mPKI segment includes all operations relating to the provision of secured access keys, authentication, signing software, certificates and digital security applications. The company was founded by Joao Carlos Creus Moreira and Philippe Doubre in 1999 and is headquartered in Zug, Switzerland.

WISeKey International Holding Ltd - ADR

WISeKey is trending with significant anticipation for its upcoming quantum-safe satellite launch via SpaceX, poised to demonstrate advanced post-quantum security chips. The community is actively discussing its potential undervaluation, considering its substantial cash reserves, strategic stake in its subsidiary, and future spin-offs like WiseSat and Sealcoin. Many investors view WKEY as a pivotal 'quantum play' with substantial upside, acknowledging its inherent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NVAX 
LT TRADE 3 to 6 Month holding period / D1 / MID Conviction
So far, clinical data shows that NVAX has the best vax product : 
1 dose
easy storage
T Cell immunity (Lasts longer, protects against symptoms and CATCHING the disease means you shed it less while asymptotic) If the P3 goes well (and looking at PFE &amp; friends it should) it should 
This is the real gold standard in vaxes - Rich countries gonna get this one and pay a premium for it. PFE/MRNA will go for 15 to 25$/ dose. this one can go for higher

They have a deal with manufacturer SPIIL which will allow them to manufacture 2bn dose / yr . 2bn * 25 = 50bn revenue. Right now NVAX trading at 5b mkt cap... . Manufacturing vaxes post R&amp;D is cheapo.

Ludovic Fortin

StockTwits Web

Novavax Inc

 
LT TRADE 3 to 6 Month holding period / D1 / MID Conviction
So far, clinical data shows that NVAX has the best vax product : 
1 dose
easy storage
T Cell immunity (Lasts longer, protects against symptoms and CATCHING the disease means you shed it less while asymptotic) If the P3 goes well (and looking at PFE & friends it should) it should 
This is the real gold standard in vaxes - Rich countries gonna get this one and pay a premium for it. PFE/MRNA will go for 15 to 25$/ dose. this one can go for higher

They have a deal with manufacturer SPIIL which will allow them to manufacture 2bn dose / yr . 2bn * 25 = 50bn revenue. Right now NVAX trading at 5b mkt cap... . Manufacturing vaxes post R&D is cheapo.